期刊文献+

血清CgA在前列腺癌诊断中的作用 被引量:1

Role of Serum Chromogranin A in the Diagnosis of Prostate Cancer
下载PDF
导出
摘要 目的探讨嗜铬粒蛋白A(CgA)在前列腺癌诊断中的作用。方法采用ELISA法测定35例前列腺癌患者、10例前列腺增生患者及30例健康志愿者血清中CgA水平。结果前列腺癌患者CgA水平高于前列腺增生患者及健康志愿者(P<0.05)。血清CgA水平随ABCD分期的升高而升高,D2期患者血清CgA水平明显高于健康志愿者及其他分期患者(P<0.05)。CgA和前列腺特异抗原(PSA)联合检测能提高前列腺癌检出率。结论血清CgA水平检测可应用于前列腺癌的诊断、监测。 Objective To evaluate the role of chromogranin A( CgA) in the diagnosis of prostate cancer. Methods Serum CgA levels were detected by using ELISA technique in 35 cases of prostate cancer,10 cases of benign prostate hyperplasia and 30 cases of healthy volunteer. Results Serum CgA levels of prostate cancer were significantly higher than those in the benign prostate hyperplasia and the healthy volunteer( P 0. 05). The serum CgA levels in the prostate cancer increased with the escalation of ABCD stage. Serum CgA levels of D2 stage prostate cancer were significantly higher than those in the healthy volunteer and in the B,C and D1 stage prostate cancer. The combined assay of serum CgA and PSA could raise the detection rate of prostate cancer. Conclusion The determination of serum levels of CgA is useful in the diagnosis and prognosis of prostate cancer.
作者 李刚 胡滨
出处 《肿瘤基础与临床》 2014年第4期332-334,共3页 journal of basic and clinical oncology
关键词 前列腺癌 嗜铬粒蛋白A 诊断 prostatic cancer chromogranin A diagnosis
  • 相关文献

参考文献8

  • 1Kadmon D, Thompson TC, Lynch GR, et al. Elevated plasma chro- mogranin-A concentrations in prostatic carcinoma [ J 1- ~ Urol, 1991,146(2) :358 -361.
  • 2Abbona G, Papotti M, Viberti L, et al. Chromogranin A gene expres- sion in non-small cell lung carcinomas [ J 1. J Pathol, 1998, 186 (2) :151 -156.
  • 3Baudin E, Gigliotti A, Ducreux M, et al. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours[ J~. Br J Cancer, 1998,78 ( 8 ) : 1102 - 1107.
  • 4Kimura N, Miura W,Noshiro T, et al. Plasma chromogranin A in pheochromocytoma,primary hyperparathyroidism and pituitary ade- noma in comparison with catecholamine, parathyroid hormone and pituitary hormones [ J ]. Endocr J, 1997,44 (2) : 319 - 327.
  • 5Ranno S, Motta M, Rampello E, et al. The chromogranin-A (CgA) in prostate cancer[J]. Arch Gerontol Geriatr, 2006,43 ( 1 ) : 117 - 126.
  • 6姚宏,王秋锁,姚巍,袁瑞香,王虹平,苏萍,赵玛丽,张庆升,纪小龙.前列腺癌组织神经内分泌细胞的免疫组化超微诊断及意义[J].中华泌尿外科杂志,1998,19(12):736-739. 被引量:6
  • 7Zitella A, Berruti A, Destefanis P, et al. Comparison between two commercially available chromogranin A assays in detecting neuro- endocrine differentiation in prostate cancer and benign prostate hy- perplasia [ J 1. Clin Chim Aeta,2007,377 ( 1/2 ) : 103 - 107.
  • 8Yamada ~,Nakamura K,Aoki S, et al. Is neuroendocrine cell dif- ferentiation detected using chromogranin A from patients with bone metastatic prostate cancer a prognostic factor for outcome [ J ]. On- col Rep,2006,15(5) :1309 - 1313.

二级参考文献3

  • 1姚宏,山西临床医药杂志,1997年,3期,52页
  • 2杨宝龙,中华泌尿外科杂志,1997年,18卷,52页
  • 3杭振镳,人体肿瘤超微结构图谱,1984年,18页

共引文献5

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部